Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
1 ,
Analyses were conducted in April 2026 and include data from 141 Noom GLP-1Rx Program members who started a GLP-1Rx plan in NovemberDecember 2025 (Sample 1) and 51 Noom GLP-1Rx Program members who started between November 2024 and June 2025 (Sample 2) and responded to a follow-up survey after discontinuation
In the meantime, heres a look at some common GLP-1 medicines used for weight loss
Product Attributes CAS-Nummer : 75921-69-6 Moleklformel : C78H111N21O19 Sequenz (AS) : Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Molekulargewicht : 1646,85 g/mol PubChem CID : 16132139 Halbwertszeit : ~30 Minuten (parenteral) Synonyme : Afamelanotid, Melanotan-1, MT-I, NDP--MSH, Scenesse Typ : Synthetisches Analogon von -MSH (Melanocortin-Rezeptor-Agonist) Forschungsschwerpunkt : Pigmentierung & Photoprotektion, Dermatologische Forschung Scientific References Afamelanotide for prevention of phototoxicity in patients with erythropoietic protoporphyria Klinische Studie | Regulatorisch Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo Klinische Studie Photoprotection by melanocortin 1 receptor agonists Tier | In vitro Afamelanotide: a melanocortin analogue for photoprotection Beobachtend | Tier The melanocortin-1 receptor: red hair and beyond In vitro | Beobachtend Melanocortin 1 receptor signaling and skin pigmentation In vitro | Tier Scenesse (afamelanotide) European Medicines Agency assessment report Regulatorisch | Klinische Studie Lieferumfang Jedes Produkt wird in einer hochwertigen, speziell entwickelten PEPTIDE.Power-Box geliefert, die fr Komfort, Hygiene und sichere Aufbewahrung im Khlschrank konzipiert wurde
US$ 23.51
US$ 21.73
US$ 28.78
US$ 22.09
